Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation | MicrobiomeTrials← Back to trialsNCT06105541
Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation
CompletedNAINTERVENTIONAL
Trial Details
Start: 2023-07-05Est. Completion: 2026-02-04
Enrollment target: 25 participants Locations- Medical University of South Carolina, Charleston, South Carolina, United States
Other microbiome trials you might be interested in
Ehlers-Danlos Syndrome (EDS)
Dysmenorrhea is a common problem in gynaecology, significantly impacting patients' quality of life. Ehlers-Danlos syndro…
Rouen, FranceEst. completion Jul 1, 2026
Ehlers-Danlos Syndrome, Hypermobile Chronic Pain Fatigue
This study evaluates the effect of photobiomodulation (PBM) therapy using a MLS® class IV laser on chronic pain and fati…
Boulogne-Billancourt, FranceEst. completion Mar 31, 2027
Hypermobile Ehlers-Danlos Syndrome
Hypermobile Spectrum Disorder
Hypermobility Type Ehlers-Danlos Syndrome
The goal of this clinical trial is to determine how strengthening the hamstring muscles affects the knee joint in people…
Calgary, CanadaEst. completion May 1, 2027